China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Real‑world Study of Brivaracetam in the Treatment of Focal Epilepsy'. The following are ... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of different doses of dexamethasone as a perineural adjunct combined with ropivac... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study on the Effects of Different Surgical Positions on the Safety and Effica... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Application Study of Physical Therapy Combined with Intra-articular Injection o... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Laparoscopic exploration and stone removal of common bile duct'. The following are the o... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Cross-Sectional Study on Differences in Specific Biomarkers Among Postmenopausal Women w... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Survey on Preferences of Home Rehabilitation Services among Elderly in Chongqing'. The f... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Comparative Study of Ultrasound-Guided Liposomal Bupivacaine Paravertebral Block versu... Read More
Singapore, Oct. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severe... Read More
Singapore, Oct. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamid... Read More